Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome

Journal: Nature Communications

Published: 2020-03-02

DOI: 10.1038/s41467-020-14959-w

Affiliations: 26

Authors: 30

Go to article
Institutions Share
Duke Department of Psychiatry and Behavioral Sciences, United States of America (USA) 0.14
Duke Proteomics and Metabolomics Shared Resource (DPMSR), United States of America (USA) 0.10
Department of Pathology and Laboratory Medicine, Penn, United States of America (USA) 0.08
Metabolomics Laboratory, Baker IDI, Australia 0.07
Institute of Bioinformatics and Systems Biology (IBIS), HMGU, Germany 0.07
Center for Innovation in Brain Science (CIBS), Arizona, United States of America (USA) 0.04
Rosa & Co. LLC, United States of America (USA) 0.03
Caryl and Israel Englander Institute for Precision Medicine (IPM), Cornell University, United States of America (USA) 0.03
Rush Alzheimer’s Disease Center (RADC), United States of America (USA) 0.03
UCSF Center for Imaging of Neurodegenerative Diseases (CIND), United States of America (USA) 0.03
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), United States of America (USA) 0.03
Duke Molecular Physiology Institute (DMPI), United States of America (USA) 0.03
Duke Department of Biostatistics and Bioinformatics, United States of America (USA) 0.03
Duke Clinical Research Institute, United States of America (USA) 0.03
Indiana Alzheimer Disease Center, IUPUI, United States of America (USA) 0.03
Department of Radiology and Imaging Sciences, IUPUI, United States of America (USA) 0.03
Duke Institute for Brain Sciences (DIBS), United States of America (USA) 0.02
Duke Department of Medicine, United States of America (USA) 0.02
School of Medical and Health Sciences, ECU, Australia 0.02
Department of Biomedical Sciences, Macquarie University, Australia 0.02
Mayo Clinic Department of Neurology, United States of America (USA) 0.02
Mayo Clinic Department of Molecular Pharmacology and Experimental Therapeutics, United States of America (USA) 0.02
Stanley H. Appel Department of Neurology, Houston Methodist, United States of America (USA) 0.02
German Center for Diabetes Research (DZD), Germany 0.02
Department of Neurology, Arizona, United States of America (USA) 0.01
Department of Pharmacology, Arizona, United States of America (USA) 0.01

Return